Special Issue "Phylogenetic Exploration of Medicinal Plants Diversity"
Deadline for manuscript submissions: closed (31 July 2018) | Viewed by 3390
According to the recent State of the World’s Plants by Kew in 2016, there are about 391,000 described plant species, of which over 31,000 (8%) have a documented use, and almost 18,000 (5%) have medicinal use. Medicinal plants have been a part of human life since prehistoric times, and remain important in all traditional cultures where they are used in a variety of ways. Although modern medicine is widely used, traditional medicine is still important to a very high proportion of the populations in both developing and developed countries. Many currently used modern medicines were originally extracted or synthetized on the basis of plant derivatives which served as blueprints. Searching for bioactive compounds from plants consumes large amounts of time, specialists, and funding. Knowledge of traditional medicinal plants can, therefore, help to reduce costs for drug discoveries. Traditional knowledge of medicinal plants is being eroded by several processes related to globalization and urbanization. It is therefore imperative to document this knowledge as soon as possible since it may be the best way to get to know more uses and medicinal species and make this knowledge available for rural communities for their use of traditional medicine, as well as for pharmaceutical discovery. In the past decade the use of phylogenetic knowledge about relatedness of taxa has been used to explore patterns of medicinal plants diversity. The assumption being that more closely related taxa are more likely to contain the same or similar compounds with medicinal properties. Examples range from the use of phylogeny to interpret cross-cultural patterns in plant use and guide medicinal plant discovery to understanding the phylogenetic distribution of psychoactive compounds in plants. New advances in molecular phylogeny provide important tools for discovering new medicinal plants and have inspired a recent new concept of ethnobotanical convergence which promises to make it easier to find new sources of natural products for health. This Special Issue will explore these and other recent developments in the phylogenetic exploration of medicinal plants discovery. The Special Issue also provides a platform for new research in the combined field of phylogeny and ethnobotany, including the preservation of traditional knowledge and of the medicinal plants it relates to.
Prof. Dr. Henrik Balslev
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diversity is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.